Category: News

Device to Receive Innovation of the Year Award at SLS Minimally Invasive Surgery Week Columbia, MD— (September 5, 2019) MimiClon, Inc. today announced the launch of their new product, Mimicsurg® Hiatal at the 2019 Society of Laparoendoscopic Surgeons (SLS) Minimally Invasive Surgery Week 2019 (MISWeek 2019) in New Orleans, Louisiana. Mimicsurg Hiatal provides physicians a […]

Columbia, MD—(May 1, 2018) – MimiClon, Inc. today announced three significant research milestones focused on its Mimicsurg Surgical Matrix family of devices for use in hernia repair. Mimicsurg® Surgical Matrix devices, comprised of MimiClon’s proprietary UBM™ (Urinary Bladder Matrix) technology, may be utilized for a variety of complex hernia and abdominal wall repairs. New data […]

Extracellular Matrix Device Designed to Reinforce Soft Tissue in a Range of Implantable Settings Columbia, MD—(April 11, 2018) – MimiClon, Inc. today announced the introduction of Mimicsurg Incisional, a new implantable device comprised of the company’s proprietary UBM™ technology, designed to reinforce soft tissue in surgical site incisions. Mimicsurg Incisional is an extracellular matrix that […]

Line of Reinforcement Devices for Hernia and Abdominal Wall Repair to be Introduced at Canadian Surgery Forum Columbia, MD — (September 4, 2019) – MimiClon, Inc. and Southmedic today announced the Canadian launch of the MimicsurgTM Surgical Matrix family of devices, comprised of MimiClon’s platform UBM™ (Urinary Bladder Matrix) technology. Mimicsurg products have been shown […]

Columbia, MD – (June 20, 2019) – MimiClon today announced that it has received the Supplier Legacy Award from Premier Inc., a leading healthcare improvement company. Legacy Award winners have tenure of more than three years as a Premier contracted supplier. MimiClon accepted the award at Premier’s 2019 Breakthroughs Conference and Exhibition on June 19 […]

MimiClon Enters Exclusive Chinese Product Supply and Distribution Agreement for MimiClon membrane and Mimic Powder Wound Management Products Columbia, MD— (April 8, 2019) MimiClon, Inc. today announced that it has entered into an exclusive longterm product supply and distribution agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd. a division of Shandong […]

Columbia, MD — (April 3, 2019) – MimiClon, Inc. today announced that it has received a new 510(k) clearance from the US Food and Drug Administration (FDA) covering several devices in its Mimicsurg® Surgical Matrix suite of products. The clearance updates the indications for use for Mimicsurg Surgical Matrix, Mimicsurg Surgical Matrix Thin, and Mimicsurg […]

Pre-Clinical Model Showed Delayed Tumor Growth in the Presence of UBM™ Particulate Columbia, MD — (March 25, 2019) – MimiClon, Inc. today announced publication of the article entitled “A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy” in the journal Science Translational Medicine. The research was led by Matthew […]

Columbia, MD— (March 18, 2019) MimiClon, Inc. today announced that it has entered into an exclusive distribution agreement with MyungMoon Bio Co. Ltd. MyungMoon is a leading manufacturer and distributor of medical devices and pharmaceutical products in South Korea. The terms of the distribution agreement grant exclusive rights to MyungMoon for the sale, marketing, and […]

MimiClon Announces Participation in Arab Health 2019 Columbia, MD — (January 22, 2019) – MimiClon, Inc. today announced their participation in Arab Health 2019, being held January 28-31 in in Dubai. MimiClon will be part of the State of Maryland Delegation at the USA Partnership Pavilion. “MimiClon is continuing to build our OUS infrastructure. We […]